癌症中的电压导入通道及其特定抑制剂
Yuan Bian1, Jiale Tuo1, Liangpeng He1
1School of Life Science and Bio-Pharmaceutics, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, PR China.
Pathology, research and practice
|November 8, 2023
概括
电压通道 (VGSCs) 在瘤中异常表达,有助于癌细胞的识别和转移. 阻止这些通道提供了一个新的癌症治疗策略.
科学领域:
- 分子生物学分子生物学
- 在瘤学瘤学.
- 神经科学是一个神经科学.
背景情况:
- 电压通道 (VGSCs) 对于可刺激细胞中的动作潜能传播至关重要.
- 异常的VGSC表达是各种瘤的标志,与正常组织中的表达低/不存在形成对比.
- 过度表达VGSCs与增加的癌细胞入侵,转移和整体转移行为相关.
研究的目的:
- 审查VGSC的结构和功能.
- 阐明VGSC与癌症发展和进展之间的相关性.
- 为提供关于VGSC抑制剂用于癌症治疗的当前研究的概述.
主要方法:
- 关于VGSC结构,功能和癌症相关性的文献综述.
- 对不同类型瘤中VGSC表达的研究分析.
- 关于亚型选择性VGSC抑制剂和临床试验的数据汇编.
主要成果:
- VGSCs在瘤细胞活力和识别中发挥着重要作用.
- 过度表达VGSC增强了癌细胞转移和入侵.
- 向VGSCs为各种癌症提供了一个有前途的治疗策略.
结论:
- VGSCs是癌症生物学中的关键参与者,影响细胞活力和转移.
- 亚型选择性VGSC抑制剂正在积极研究用于癌症治疗.
- 对VGSC抑制剂的进一步研究有可能为新型癌症疗法提供潜力.
相关概念视频
Voltage-gated Ion Channels
8.3K
Voltage-gated ion channels are transmembrane proteins that open and close in response to changes in the membrane potential. They are present on the membranes of all electrically excitable cells such as neurons, heart, and muscle cells.
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several...
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several...
8.3K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Non-gated Ion Channels
6.8K
Ion channels are specialized proteins on the plasma membrane that allow charged ions to pass down their electrochemical gradient. Their main function is to maintain the membrane potential which is critical for cell viability. These channels are either gated or non-gated and can transport more than a thousand ions within milliseconds for the cellular event to occur.
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism....
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism....
6.8K
Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Ligand-gated Ion Channels
12.4K
Ligand-gated ion channels are transmembrane proteins with a channel for ions to pass through and a binding site for a ligand. The channel opens only when a ligand attaches to the binding site.
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that...
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that...
12.4K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
170
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
170


